CHO Plus is creating regulatory compliant genetically engineered mammalian cells to be used by biopharmaceutical companies for therapeutic protein manufacturing. Early proof of concept experiments demonstrate CHO Plus cells to be 4.5-fold more productive than parent cells in model system. The CHO Plus approach includes patented methods for genetically engineering mammalian cells; proprietary and patented targeted transfection technology; and efficient clone screening technology.
View Top Employees from CHO Plus, Inc.| Website | http://cho-plus.com/ |
| Revenue | $3 million |
| Employees | 10 (5 on RocketReach) |
| Founded | 2014 |
| Address | 329 Oyster Point Blvd, South San Francisco, California 94080, US |
| Phone | (845) 380-6993 |
| Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular CHO Plus, Inc. employee's phone or email?
CHO Plus, Inc. Questions
The CHO Plus, Inc. annual revenue was $3 million in 2024.
James Panek is the COO of CHO Plus, Inc..
5 people are employed at CHO Plus, Inc..
CHO Plus, Inc. is based in South San Francisco, California.
The NAICS codes for CHO Plus, Inc. are [5417, 541713, 541, 54171, 54].
The SIC codes for CHO Plus, Inc. are [873, 87].
Top CHO Plus, Inc. Employees
-
35
-
22
-
11
Related Companies
